Jafco Life Science

Jafco Life Science

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Japan, Tokyo

About

This investor is located in Asia, Japan. The the headquarters of this VC is in Tokyo.

The fund typically invests in rounds with 5-6 participants. Aside from Jafco Life Science, start-ups are often funded by Versant Ventures, Pittsburgh Life Sciences Greenhouse, Wilson Sonsini Goodrich & Rosati. The most common co-investors for the fund are WS Investments, Versant Ventures, Scottish Widows Investment Partnership. In subsequent rounds, the fund is usually supported by Sofinnova Investments, RCT BioVentures, Novartis Venture Fund, out of 5 investors from our database.

The highest number of exits from this fund were in 2012. The fund performance shows that this VC achieves 13 percentage points more exits in comparison to other VCs. The most common rounds for this fund are in the range of 10 - 50 millions dollars. Jafco Life Science is involved in 21 percentage points more than the average amount of lead investments when compared with other funds. The fund's activity peaked in 2003. The fund generally invests in less than 2 deals every year.

The country of its establishment and the country of its most frequent investments doesn't coincide - United States. Also, a start-up has to be aged 4-5 years to expect investment from this fund. The fund has no a preferred number of founders for start-ups that it invests in. If there are 5+ founders in the start-up, the probability of getting the investment is low. Kythera Biopharmaceuticals, Lucid Motors, Catalyst Biosciences are amongst the various portfolio companies of this fund. We can highlight the most popular investment areas for this fund, such as Therapeutics, Health Care. In addition, there are 9 more industries where it has achieved success.

Besides the listed founders, we have found 5 key employees of this fund in our database.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: jafcoasia.com; User name format in descending order of probability: first '.' last, first_initial '.' last, first '_' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x10

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

21.3 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.23 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

1

Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]

1

Funds Investing in Following
Rounds

Sofinnova Investments, RCT BioVentures, Novartis Venture Fund

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: